Firms
Theme

GSBD

Goldman Sachs BDC, Inc. · NYSE

News

8 latest

Zacks Investment Research

New Strong Buy Stocks for October 9th

Zacks has added five stocks to its Strong Buy list based on positive earnings estimate revisions over the last 60 days. The stocks include Lumentum Holdings (optical/photonic products), Werewolf Therapeutics (cancer biopharmaceutical), Perion Network (digital advertising), Goldman Sachs BDC (business development), and Griffon Corporation (diversified management).

Zacks Investment Research

Best Value Stocks to Buy for October 9th

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong value characteristics: Perion Network Ltd. (PERI) with a P/E of 7.42 and 14.7% earnings estimate increase; Griffon Corporation (GFF) with a P/E of 14.91 and 5.5% earnings estimate increase; and Goldman Sachs BDC, Inc. (GSBD) with a P/E of 6.85 and 12.2% earnings estimate increase.

Zacks Investment Research

Best Income Stocks to Buy for October 9th

Zacks highlights two Rank #1 stocks with strong income potential: Goldman Sachs BDC (GSBD) with a 14.5% dividend yield and 12.2% earnings estimate increase, and Banco Bilbao Vizcaya Argentaria (BBVA) with a 4.3% dividend yield and 4.9% earnings estimate increase.

Zacks Investment Research

New Strong Buy Stocks for October 6th

Zacks has added five stocks to its Strong Buy list today: Sandisk Corporation, Calumet Inc., Chevron Corporation, H&R Block Inc., and Goldman Sachs BDC Inc. All five companies have seen their consensus earnings estimates increase over the last 60 days, ranging from 8.1% to 15.3%.

Zacks Investment Research

Best Income Stocks to Buy for October 6th

Zacks highlights three Rank #1 stocks with strong income characteristics: Goldman Sachs BDC with a 14.1% dividend yield and 12.2% earnings estimate increase; H&R Block with a 4.4% dividend yield and 8.1% earnings estimate increase; and Canadian Natural Resources with a 3.7% dividend yield and 6% earnings estimate increase.

Zacks Investment Research

Zacks Industry Outlook Highlights Goldman Sachs BDC, Gladstone Investment and Runway Growth Finance

The SBIC & Commercial Finance industry is positioned to benefit from higher interest rates and wider investment spreads, with resilient economic growth supporting demand for customized financing. However, rising concerns around private credit, increased non-accruals, and credit losses pressure asset quality. Three stocks highlighted are Goldman Sachs BDC (Zacks Rank #1), Gladstone Investment (Zacks Rank #1), and Runway Growth Finance (Zacks Rank #2), all expected to benefit from elevated rates given their floating-rate portfolios.

Zacks Investment Research

3 SBIC & Commercial Finance Stocks to Buy on Improving Industry Trends

The SBIC & Commercial Finance industry is positioned to benefit from higher interest rates, which boost investment income on floating-rate portfolios, and regulatory changes enhancing funding flexibility. However, rising concerns about private credit, increased non-accruals, and credit losses pose risks to asset quality. Three stocks are highlighted as well-positioned: Goldman Sachs BDC, Gladstone Investment Corporation, and Runway Growth Finance Corp.

Zacks Investment Research

Best Income Stocks to Buy for September 30th

Zacks highlights three stocks with Strong Buy ratings and attractive dividend yields: Goldman Sachs BDC (13.5% yield), Gray Media Inc. (7.1% yield), and Industrial Logistics Properties Trust (5.6% yield). All three have seen positive earnings estimate revisions over the last 60 days.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $GSBD · 0 threads

Sign in to post on $GSBD

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev